- Report
- October 2024
- 183 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 136 Pages
Global
From €4767EUR$4,995USD£3,994GBP
-
Journal - March 2025
- 58 Pages
Global
From €406EUR$425USD£340GBP
- Book
- November 2022
- 400 Pages
- Book
- November 2022
- 512 Pages
- Book
- April 2022
- 480 Pages
- Book
- December 2020
- 856 Pages
- Book
- January 2016
- 360 Pages
- Book
- August 2010
- 355 Pages
- Book
- August 2022
- 500 Pages
The Drug Synthesis market is a subset of the Drug Discovery market, which focuses on the development of new drugs. Drug Synthesis involves the chemical synthesis of compounds that can be used as potential drug candidates. This process involves the use of organic chemistry techniques to create molecules that can be tested for their potential therapeutic effects. The Drug Synthesis market is a highly competitive space, with companies investing heavily in research and development to create new compounds.
The Drug Synthesis market is driven by the need for new drugs to treat a variety of diseases. Companies in this market are constantly looking for new ways to create compounds that can be used as potential drug candidates. This includes the use of new technologies, such as artificial intelligence and machine learning, to create more efficient and cost-effective drug synthesis processes.
Some companies in the Drug Synthesis market include Merck, Pfizer, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more